Quick Summary
Covering the latest research from top Wall Street investment banks

JMTBA April 2026 orders showed strong year-over-year growth, supporting share-price catalysts for AirTAC and Hiwin

Institution
Morgan Stanley
Date
2026-05-17
Authors
Sharon Shih, Derrick Yang
Company
AirTAC International; Hiwin Technologies Corp.
Ticker
1590.TW; 2049.TW
Industry
Greater China Technology Hardware; Industrial Automation
Rating
Industry View In-Line; AirTAC International Overweight; Hiwin Technologies Corp. Overweight
NeutralLow confidenceApril 2026 JMTBA headline orders rose 45% YoY despite a 2% MoM decline, overseas orders remained strong, PMIs in China, Europe and North America stayed above 50, and Morgan Stanley remained Overweight on both AirTAC and Hiwin.
AuthorsSharon Shih, Derrick Yang
CoverageChina、United States、Asia-Pacific、Europe
Asset classesEquity
Business segmentsindustrial automation components、machine tool demand、pneumatic components、linear guideways、humanoids
Research firm divisions/subsidiariesMorgan Stanley(Other)、Morgan Stanley Asia Limited(Other)、Morgan Stanley Taiwan Limited(Other)

AI summary card

JMTBA April 2026 orders showed strong year-over-year growth, supporting share-price catalysts for AirTAC and Hiwin

Morgan Stanley believes that although preliminary JMTBA orders for April 2026 fell 2% month over month, they increased 45% year over year to JPY189 billion, showing that the recovery in industrial automation demand remains resilient and could become a share-price catalyst for AirTAC International and Hiwin Technologies Corp.

Industry View is In-Line; AirTAC International (1590.TW) and Hiwin Technologies Corp. (2049.TW) are both Overweight, and Morgan Stanley's relative rating typically corresponds to risk-adjusted total return expectations over the next 12 to 18 months versus the covered universe.
Greater China Technology HardwareIndustrial AutomationRoboticsMachine Tool OrdersAirTAC InternationalHiwin Technologies Corp.OverweightIndustry View In-Line
  • Total JMTBA orders for April 2026 were JPY189 billion, down 2% month over month but up 45% year over year, versus 32% month-over-month growth and 28% year-over-year growth in March, indicating that the year-over-year growth momentum strengthened further.
  • Domestic orders were JPY49 billion, down 2% month over month and up 43% year over year; overseas orders were JPY140 billion, down 2% month over month and up 46% year over year.
  • April manufacturing PMIs for China, Europe and North America were 50.3, 52.2 and 52.7, respectively, all above the 50 expansion threshold, supporting the view that overseas orders remain strongly supported year over year.
  • Morgan Stanley maintained its Overweight view on AirTAC and Hiwin: AirTAC benefits from continued market-share gains and an undemanding valuation, while Hiwin benefits from higher utilization, price increases and margin expansion in the second half of the year.

Report interpretation

Overview

This report uses the Japan Machine Tool Builders' Association, or JMTBA, preliminary April 2026 order data as an entry point to observe demand signals for industrial automation and Greater China technology hardware names. The report notes that total JMTBA orders in April edged down month over month but rose sharply year over year, while overseas orders remained strong year over year. Combined with manufacturing PMIs in major regions remaining in expansion territory, this suggests that the industry recovery still has reasonable momentum. Morgan Stanley believes these data may act as catalysts for AirTAC International and Hiwin Technologies Corp. shares.

Core views

The key views are: first, total JMTBA orders reached JPY189 billion in April, up 45% year over year, indicating that the industry demand recovery is still continuing; second, overseas orders grew 46% year over year, and PMIs in China, Europe and North America all remained above 50, providing broad-based support for regional demand; third, AirTAC is expected to continue gaining market share, and its 22x 2027e P/E is below the 25x average since 2020, so valuation is not considered expensive; fourth, Hiwin is likely to see margin expansion over the next several quarters, especially in the second half of 2026, thanks to higher utilization and price increases. Although its 37x 2027e P/E is not cheap, there is still room for upward earnings revisions if demand momentum continues.

Analysis framework

The report combines a top-down review of industry order data with a bottom-up assessment of individual stock valuation and earnings leverage. At the industry level, it tracks JMTBA machine-tool orders, the split between domestic and overseas orders, and PMIs in major regions; at the company level, it evaluates AirTAC's market share and valuation, Hiwin's margin expansion, price increases, utilization improvement and potential humanoid-robot revenue contribution.

Methodology notes

  • industry_indicatorJMTBA preliminary orders

    Using Japanese machine-tool orders as a leading or coincident indicator of industrial automation demand

    The report treats changes in JMTBA's preliminary April 2026 orders as the core data source for judging the recovery in automation demand and potential stock catalysts, with a focus on month-over-month and year-over-year changes as well as the domestic and overseas order mix.

  • macro_indicatorManufacturing PMI threshold

    Using 50 as the dividing line between manufacturing expansion and contraction

    China, Europe and North America PMIs in April were 50.3, 52.2 and 52.7, respectively, all above 50, and were used to support the view that overseas demand remains resilient.

  • Valuation methodsP/E multiple valuation

    Assessing fair value based on expected 2027 earnings and a target P/E multiple

    AirTAC uses a base-case 30x 2027e P/E to reflect earnings growth momentum for industrial automation component companies in an upcycle; Hiwin uses a 37x 2027e P/E, supported by an expected 44% CAGR in operating profit from 2025 to 2028.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • AirTAC International (1590.TW)
    A beneficiary of the industrial automation recovery; the report maintains Overweight
    Strengths
    It is expected to continue gaining market share; its 22x 2027e P/E is below the 25x average since 2020; if the industry enters an upcycle, a 30x 2027e P/E base case is viewed as reasonable.
    Weaknesses
    Downside risks disclosed in the report include a sharper slowdown in China, a longer-than-expected development cycle for mini linear guideways, and higher-than-expected new-product investment with weaker-than-expected demand.
    Comparison
    Relative to its historical average, AirTAC's current valuation is described as not expensive; relative to Hiwin, the AirTAC thesis leans more toward market-share gains and valuation re-rating.
    Risks
    A weaker macro environment in China, industrial automation demand falling short of expectations, and uncertainty around the returns on new-product investments.
  • Hiwin Technologies Corp. (2049.TW)
    A beneficiary of industrial automation demand recovery, margin improvement and potential humanoid-robot contributions; the report maintains Overweight
    Strengths
    It may benefit over the next several quarters, especially in the second half of 2026, from margin expansion driven by higher utilization and price increases; if demand momentum persists, earnings estimates may be revised upward; earlier-than-expected humanoid-robot revenue contribution represents upside risk.
    Weaknesses
    Its 37x 2027e P/E is not cheap, and it is already near the 35-40x peak-cycle valuation range, which implies a high bar for sustained demand and earnings delivery.
    Comparison
    Compared with AirTAC, Hiwin has a higher valuation, but its margin-expansion and earnings-revision leverage is more pronounced.
    Risks
    A slowdown in industrial automation demand, greater pricing pressure, market-share loss, and broader spillovers from geopolitical risk to the global economy.
  • Greater China Technology Hardware / Industrial Automation
    JMTBA orders and manufacturing PMIs provide the industry demand readout; the industry view is In-Line
    Strengths
    April JMTBA orders rose 45% year over year, overseas orders rose 46% year over year, and PMIs in major regions remained above 50, showing that the demand recovery has some breadth.
    Weaknesses
    Total, domestic and overseas orders in April all fell 2% month over month, indicating that near-term momentum is not improving in a straight line.
    Comparison
    The industry view is In-Line, while AirTAC and Hiwin are preferred at the stock level.
    Risks
    A global manufacturing downturn, weaker China macro conditions, geopolitical shocks, and intensifying price competition.

Key data

  • JMTBA April 2026 total orders¥189bnDown 2% month over month, up 45% year over year; March was up 32% month over month and 28% year over year.
  • JMTBA April 2026 domestic orders¥49bnDown 2% month over month, up 43% year over year; March was up 36% month over month and 2% year over year.
  • JMTBA April 2026 overseas orders¥140bnDown 2% month over month, up 46% year over year; March was up 30% month over month and 40% year over year.
  • April manufacturing PMIs in key regionsChina 50.3, Europe 52.2, North America 52.7All above 50; March was 50.4, 51.6 and 52.7, respectively.
  • AirTAC valuation22x 2027e P/EBelow the 25x average since 2020; the report считает valuation is not expensive.
  • AirTAC base-case valuation method30x 2027e P/EThe report considers peak-cycle valuation reasonable once the industry enters an upcycle.
  • Hiwin valuation37x 2027e P/ENear the 35-40x peak-cycle valuation range; the report believes earnings estimates may still have room to rise if demand persists.
  • Hiwin earnings growth assumption44% operating profit CAGR for 2025-28Used to support the 37x 2027e P/E target multiple.

Impact & implications

From an investment perspective, the strong year-over-year JMTBA orders and manufacturing PMIs across major global regions within expansion territory have improved market confidence in the industrial automation recovery. For AirTAC, the key implication is that market-share gains and a relatively modest valuation may support a re-rating in the share price. For Hiwin, the key implication is that higher utilization, price increases and margin expansion in the second half of 2026 may drive earnings revisions higher. The industry-level view remains In-Line, indicating that the report emphasizes stock-specific opportunities rather than a broad upgrade of the industry view.

Risks

  • A sharper deterioration in China's macroeconomy could weaken industrial automation demand.
  • A weaker-than-expected recovery in industrial automation demand would affect revenue and margin improvement at AirTAC and Hiwin.
  • Hiwin may face greater pricing pressure, market-share losses and spillover from global geopolitical risks.
  • AirTAC's mini linear guideway business may take longer to develop, and if new-product investment runs ahead of expectations while demand stays weak, returns will be pressured.
  • Morgan Stanley discloses that it or its affiliates may have investment banking, market-making, shareholding or other business relationships with the covered companies, and investors should treat this research as only one factor in their investment decisions.

What to watch

  • The month-over-month and year-over-year trend in subsequent JMTBA orders, especially whether overseas orders remain strong.
  • Whether manufacturing PMIs in China, Europe and North America continue to stay above 50.
  • Whether AirTAC's market-share gains are realized and whether its valuation re-rates toward historical averages or peak-cycle multiples.
  • The magnitude of Hiwin's utilization improvement, price implementation and margin expansion in the second half of 2026.
  • Whether actual humanoid-robot revenue contribution to Hiwin arrives earlier than expected.
  • The impact of China's macro environment, the global manufacturing cycle and geopolitical risk on industrial automation demand.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins